Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy

[11] Zhang T(2009)Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy J Virol 83 11876-194

[12] Hoffmann M(2015)Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients Mediat Inflamm 2015 395484-1744

[13] Pantazis N(2021)Primary Care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis 73 e3572-S33

[14] Martin GE(2014)Automated identification of stratifying signatures in cellular subpopulations Proc Natl Acad Sci USA 111 E2770-2756

[15] Hickling S(2014)Revised surveillance case definition for HIV infection—United States, 2014 MMWR Recomm Rep 63 1-479

[16] Hurst J(2020)Cancer and HIV-1 infection: patterns of chronic antigen exposure Front Immunol 11 1350-1259

[17] Meyerowitz J(2015)HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles J Acquir Immune Defic Syndr 68 377-58

[18] Sun Y(2014)HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality PLoS Pathog 10 e1004078-662

[19] Xue J(2016)T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment J Infect Dis 214 216-7101

[20] Calvet-Mirabent M(2019)Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy AIDS 33 1645-undefined

[11] Zhang T(2009)Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy J Virol 83 11876-194

[12] Hoffmann M(2015)Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients Mediat Inflamm 2015 395484-1744

[13] Pantazis N(2021)Primary Care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis 73 e3572-S33

[14] Martin GE(2014)Automated identification of stratifying signatures in cellular subpopulations Proc Natl Acad Sci USA 111 E2770-2756

[15] Hickling S(2014)Revised surveillance case definition for HIV infection—United States, 2014 MMWR Recomm Rep 63 1-479

[16] Hurst J(2020)Cancer and HIV-1 infection: patterns of chronic antigen exposure Front Immunol 11 1350-1259

[17] Meyerowitz J(2015)HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles J Acquir Immune Defic Syndr 68 377-58

[18] Sun Y(2014)HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality PLoS Pathog 10 e1004078-662

[19] Xue J(2016)T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment J Infect Dis 214 216-7101

[20] Calvet-Mirabent M(2019)Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy AIDS 33 1645-undefined